|

AUGUST 5, 2015

Latham, Davis Polk provide counsel on Aimmune's $160 million IPO

Latham & Watkins advised Brisbane-based Aimmune Therapeutics Inc. in pricing its initial public offering. The company is selling 10 million shares of common stock at a price of $16 per share. The underwriters in the deal have an option to purchase an additional 1,499,999 shares.

Menlo Park-based partners Patrick Pohlen and Brian Cuneo led the Latham team, with the help of associates Miles Jennings, Patrick Watkins and Nicole Fritz. The Latham team included Menlo Park-based partners Judith Hasko and James Metz and associates Gavin Liu and Jessica Chen, along with San Francisco-based partner Grace M. L. Chen, associate Julie Crisp and counsel Betty Pang. Washington, D.C.-based partner John Manthei and associates Elizabeth Richards and Eitan Bernstein provided assistance, with the help of Brussels-based partner Héctor Armengod.